Maryam Mirahmad

Circular RNAs in Alzheimer’s Disease: A New Perspective of Diagnosticand Therapeutic Targets

Omid Vakili, Pooria Asili, Zeinab Babaei et al. · CNS & Neurological Disorders - Drug Targets · 2022 · 29 citations

The association between advanced glycation end products (AGEs) and ABC (hemoglobin A1C, blood pressure, and low-density lipoprotein cholesterol) control parameters among patients with type 2 diabetes mellitus

Mohaddeseh Rezaei, Soghra Rabizadeh, Maryam Mirahmad et al. · Diabetology & Metabolic Syndrome · 2022 · 25 citations · Full text

Evaluation of novel 2-(quinoline-2-ylthio)acetamide derivatives linked to diphenyl-imidazole as α-glucosidase inhibitors: Insights from in silico, in vitro, and in vivo studies on their anti-diabetic properties

Minoo Khalili Ghomi, Milad Noori, Maryam Mirahmad et al. · European Journal of Medicinal Chemistry · 2024 · 18 citations · Full text

Medicinal Chemistry, α-Glucosidase Inhibitors, Vivo Studies +11

Hyperandrogenism and anthropometric parameters in women with polycystic ovary syndrome

Asieh Mansour, Maryam Noori, Monir Sadat Hakemi et al. · BMC Endocrine Disorders · 2024 · 17 citations · Full text

Infertility, Female Infertility, Gender Studies +14

Risk factors for insulin resistance related to polycystic ovarian syndrome in Iranian population

Asieh Mansour, Maryam Mirahmad, Mohammad Reza Mohajeri‐Tehrani et al. · Scientific Reports · 2023 · 15 citations · Full text